|
Mitaban Liquid
View other items in the same category as Mitaban Liquid Product UsesMitaban is indicated for treatment of generalized demodicosis (Demodex canis) in dogs. Current data do not support use for treatment of localized demodicosis or scabies. Product Containsamitraz Dosage and AdministrationLong and medium-haired dogs should be clipped closely before treating. Prior to Mitaban treatment, dogs should be bathed with a mild soap and water and towel dried. The entire animal should then be topically treated with Mitaban at a rate of 10.6 milliliters (contents of one bottle) per 2 gallons of warm water. Two bottles (21.2 milliliters) per four gallons of water may be necessary to treat large dogs. The entire dog should be completely wetted with the mixture, and then allowed to air dry. Do not rinse or towel dry the dog after treatment with Mitaban. Three to six topical treatments (14 days apart) are recommended for treatment of generalized demodicosis. It is important to continue the treatment until no viable (alive) mites are found in the skin scrapings at two successive treatments, or until six treatments have been applied. Severe cases may require a second and third series of therapy. Treatment of dogs which do not respond clinically should be discontinued. Warnings, Side Effects and Drug InteractionsAmitraz may alter the animal's ability to maintain normal body function. Animals treated with Mitaban should not be subjected to stress for a period of at least 24 hours post-treatment. The most frequently observed adverse reaction in the clinical studies was transient sedation, within 2 to 6 hours post-treatment, and usually dissipated within 24 to 72 hours. Transient itching, due to an indirect effect due to an inflammatory reaction associated with dead mites was also occasionally seen following treatment. Convulsions, an unsteady gait, hyperexcitability, personality change, hypothermia, appetite stimulation, bloat, excess urination, vomiting, diarrhea, anorexia, reddening of the skin and death were also been rarely observed following treatment. It is not known whether Mitaban may cause impairment of fertility in dogs, nor whether Mitaban may harm the embryo or fetus of pregnant animals. The safety of Mitaban has not been established for dogs less than four months of age. Mitaban (concentrate or diluted) may cause eye or skin irritation in sensitive persons. Do not get in eyes, on skin or on clothing. If in eyes, wash with water for 15 minutes and call a physician immediately. Protect exposed skin (e.g. with rubber gloves, etc.) when mixing Mitaban with water and treating animals. Wash hands and arms with soap and water after treatment of the pet(s). Avoid handling pets immediately after treatment. Contact may cause skin irritation in sensitive individuals during the first few days after treatment. Ingestion or inhalation may cause central nervous system depression. Ingestion of Mitaban may increase the risk of adverse effects. StorageStore at controlled room temperature 20° to 25°C (68° to 77°F) ManufacturerPfizer Animal Health Registration StatusNADA #120-299, Approved by FDA Federal law restricts this drug to use by or on the order of a licensed veterinarian.
|